KLIRFIBA
Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, protein aggregation-related diseases and disorders, neurodegenerative diseases and disorders
Pending · October 11, 2021 · 97068218 ·